AR020610A1 - Utilizacion de un copolimero de acido metacrilico de tipo c segun la farmacopea us national formulary usp/nf, como agente de desagregacion y el procedimiento de fabricaion de un comprimido con dicho copolimero - Google Patents

Utilizacion de un copolimero de acido metacrilico de tipo c segun la farmacopea us national formulary usp/nf, como agente de desagregacion y el procedimiento de fabricaion de un comprimido con dicho copolimero

Info

Publication number
AR020610A1
AR020610A1 ARP990103559A ARP990103559A AR020610A1 AR 020610 A1 AR020610 A1 AR 020610A1 AR P990103559 A ARP990103559 A AR P990103559A AR P990103559 A ARP990103559 A AR P990103559A AR 020610 A1 AR020610 A1 AR 020610A1
Authority
AR
Argentina
Prior art keywords
agent
tablet
type
degregation
pharmacopea
Prior art date
Application number
ARP990103559A
Other languages
English (en)
Original Assignee
Permatec Tech Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Permatec Tech Ag filed Critical Permatec Tech Ag
Publication of AR020610A1 publication Critical patent/AR020610A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Abstract

Se revela la utilizacion de un copolímero de ácido metacrílico de tipo C segun la farmacopea US National Formulary USP/NF, caracterizada porque comprendesu aplicacion como agente, o co agente de desagregacion en un comprimido. También se revela el procedimiento de fabricacion de comprimidos en dicho copolímero.
ARP990103559A 1998-07-20 1999-07-20 Utilizacion de un copolimero de acido metacrilico de tipo c segun la farmacopea us national formulary usp/nf, como agente de desagregacion y el procedimiento de fabricaion de un comprimido con dicho copolimero AR020610A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9809221A FR2781152B1 (fr) 1998-07-20 1998-07-20 Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation

Publications (1)

Publication Number Publication Date
AR020610A1 true AR020610A1 (es) 2002-05-22

Family

ID=9528780

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990103559A AR020610A1 (es) 1998-07-20 1999-07-20 Utilizacion de un copolimero de acido metacrilico de tipo c segun la farmacopea us national formulary usp/nf, como agente de desagregacion y el procedimiento de fabricaion de un comprimido con dicho copolimero

Country Status (17)

Country Link
US (1) US6696085B2 (es)
EP (1) EP0974365B1 (es)
JP (1) JP2000044490A (es)
KR (1) KR20000011772A (es)
AR (1) AR020610A1 (es)
AT (1) ATE276769T1 (es)
AU (1) AU765915B2 (es)
CA (1) CA2277878C (es)
DE (2) DE974365T1 (es)
DK (1) DK0974365T3 (es)
ES (1) ES2144989T3 (es)
FR (1) FR2781152B1 (es)
IL (1) IL130875A (es)
NZ (1) NZ336789A (es)
PT (1) PT974365E (es)
TW (1) TWI254640B (es)
ZA (1) ZA994470B (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024380A1 (en) * 1998-10-27 2000-05-04 Fuisz Technologies Ltd. Microparticles containing peg and/or peg glyceryl esters
US7815937B2 (en) * 1998-10-27 2010-10-19 Biovail Laboratories International Srl Quick dissolve compositions and tablets based thereon
US7074392B1 (en) 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US8257688B2 (en) 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
EP1167433A1 (de) * 2000-06-19 2002-01-02 Mifa Ag Frenkendorf Mit unlöslichem Sprengmittel coprozessiertes Polysaccharidprodukt, Herstellungsverfahren und Verwendung davon
WO2002002081A1 (en) * 2000-07-05 2002-01-10 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001280194A1 (en) * 2000-08-29 2002-03-13 Daido Chemical Corporation Resin composition
BR0212951A (pt) * 2001-09-28 2004-10-26 Mcneil Ppc Inc Formas de dosagens compósitas
CA2409552A1 (en) * 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
DE10304403A1 (de) 2003-01-28 2004-08-05 Röhm GmbH & Co. KG Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung
US20050147663A1 (en) 2003-07-17 2005-07-07 Mohan Mailatur S. Method of treatment for improved bioavailability
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
US7879354B2 (en) 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8067029B2 (en) 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8268791B2 (en) 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
EP1839650A1 (en) * 2004-12-28 2007-10-03 Eisai R&D Management Co., Ltd. Quick disintegration tablet and method of producing the same
US20060275364A1 (en) * 2005-05-26 2006-12-07 Ahmed Salah U Flexible Solid Dosage Forms and Methods of Making and Using the Same
EP1909767A2 (en) * 2005-07-28 2008-04-16 Supernus Pharmaceuticals, Inc. Modified release tablet formulations with enhanced mechanical properties
US20070104782A1 (en) * 2005-07-28 2007-05-10 Ibrahim Melissa E Modified release tablet formulations with enhanced mechanical properties
RU2435573C2 (ru) * 2005-07-28 2011-12-10 ШИР ЭлЭлСи Фармацевтические составы на основе гуанфацина, подходящие для ежедневного введения в виде единичной дозированной формы
DE202006020168U1 (de) 2005-12-21 2008-07-17 Basf Se Pharmazeutische Formulierung für die Herstellung von schnell zerfallenden Tabletten
FR2896157B1 (fr) 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
RS51330B (en) * 2006-02-09 2011-02-28 Teva Pharmaceutical Industries Ltd. STABLE PHARMACEUTICAL FORMULATIONS OF MONTELUKAST SODIUM
US20070196494A1 (en) * 2006-02-17 2007-08-23 Arnaud Grenier Low-friability, patient-friendly orally disintegrating formulations
EP2034953A4 (en) * 2006-06-26 2013-05-15 Capricorn Pharma Inc ORAL DISINTEGRATING LAYER COMPOSITIONS
US20080263000A1 (en) * 2007-01-26 2008-10-23 John Randall West Utilizing aggregated data
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
CN101686931B (zh) * 2007-06-06 2013-06-19 巴斯夫欧洲公司 用于制备可咀嚼片剂和锭剂的药物配制剂
CA2686964A1 (en) * 2007-06-06 2008-12-11 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
WO2008148731A1 (de) * 2007-06-06 2008-12-11 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
EP2170273B1 (de) * 2007-06-06 2014-11-26 Basf Se Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten
US9072670B2 (en) * 2007-10-19 2015-07-07 Otsuka Pharmaceutical Co., Ltd. Matrix-type pharmaceutical solid preparation
DE102008012295A1 (de) * 2008-03-03 2009-09-17 Südzucker AG Mannheim/Ochsenfurt Gemisch zur Herstellung von schnell zerfallenden Tabletten
CN102988318A (zh) 2008-11-25 2013-03-27 田边三菱制药株式会社 口腔速崩片及其制备方法
EP2405905B1 (en) * 2009-03-09 2016-06-29 SPI Pharma, INC. Highly compactable and durable direct compression excipients and excipient systems
BR112012010102B8 (pt) 2009-10-28 2021-05-25 Basf Se material de revestimento, uso de materiais de revestimento, e, revestimentos de película para formas de dosagem farmacêuticas
EP2612657B1 (en) 2010-08-31 2023-08-09 Kyowa Kirin Co., Ltd. Orodispersible tablet
CN103189052A (zh) 2010-09-07 2013-07-03 巴斯夫欧洲公司 基于含氨基聚合物的共聚物作为基质粘合剂在制备含活性成分的颗粒和给药形式中的用途
CN103221038B (zh) 2010-09-27 2019-05-07 巴斯夫欧洲公司 酸性活性成分的保护涂层
US9795576B2 (en) 2010-09-27 2017-10-24 Basf Se Protective coatings for acidic active ingredients
US8715729B2 (en) 2010-12-22 2014-05-06 Basf Se Rapidly disintegrating, solid coated dosage form
JP6521564B2 (ja) 2010-12-22 2019-05-29 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 速崩性の固体被覆剤形
US8962064B2 (en) 2011-02-28 2015-02-24 Basf Se Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
WO2012116941A1 (de) 2011-02-28 2012-09-07 Basf Se Herstellung von pulverförmigen überzugsmitteln für stabile protektive überzüge für pharmazeutische dosierungsformen
US8865250B2 (en) 2011-02-28 2014-10-21 Basf Se Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms
BR112013020877B1 (pt) 2011-02-28 2020-06-02 Basf Se Processo para produzir composições de revestimento pulverulentas
CN103415284B (zh) 2011-03-09 2016-12-07 巴斯夫欧洲公司 用于制备快速崩解的片剂的药物配制物
EP2833880B1 (en) * 2012-04-02 2017-08-23 Pharma Seeds Create, LLC Ibuprofen solid oral dosage composition comprising a methacrylic acid copolymer
TW201521794A (zh) * 2013-11-12 2015-06-16 Daiichi Sankyo Co Ltd 錠劑
EP3135272A1 (en) 2015-08-31 2017-03-01 Basf S.A. Compositions for mouth wash in the form of tablets
BR102016023115A2 (pt) * 2016-10-04 2018-05-02 Prati, Donaduzzi & Cia Ltda Composição farmacêutica e alimento em formato de tablete
KR102120720B1 (ko) * 2018-07-16 2020-06-10 연성정밀화학(주) 날푸라핀 함유 구강붕해정

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD143213A1 (de) * 1979-04-25 1980-08-13 Michael Dittgen Verfahren zur granulierung
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
DE4036757A1 (de) * 1990-11-17 1992-05-21 Bayer Ag Antazida-zubereitung mit verlaengerter magenverweilzeit
US6074669A (en) * 1997-01-20 2000-06-13 Ranbaxy Laboratories Limited Controlled drug delivery system for diltiazem

Also Published As

Publication number Publication date
TWI254640B (en) 2006-05-11
US6696085B2 (en) 2004-02-24
DE69920344T2 (de) 2005-10-06
DE974365T1 (de) 2000-05-04
ES2144989T1 (es) 2000-07-01
ZA994470B (en) 2000-01-28
DK0974365T3 (da) 2005-01-31
ATE276769T1 (de) 2004-10-15
DE69920344D1 (de) 2004-10-28
FR2781152B1 (fr) 2001-07-06
EP0974365B1 (fr) 2004-09-22
JP2000044490A (ja) 2000-02-15
AU3906699A (en) 2000-02-10
FR2781152A1 (fr) 2000-01-21
KR20000011772A (ko) 2000-02-25
IL130875A (en) 2005-12-18
ES2144989T3 (es) 2005-04-16
NZ336789A (en) 2000-11-24
US20020168404A1 (en) 2002-11-14
IL130875A0 (en) 2001-01-28
CA2277878A1 (fr) 2000-01-20
CA2277878C (fr) 2010-11-16
PT974365E (pt) 2005-02-28
AU765915B2 (en) 2003-10-02
EP0974365A1 (fr) 2000-01-26

Similar Documents

Publication Publication Date Title
AR020610A1 (es) Utilizacion de un copolimero de acido metacrilico de tipo c segun la farmacopea us national formulary usp/nf, como agente de desagregacion y el procedimiento de fabricaion de un comprimido con dicho copolimero
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
ATE329579T1 (de) Feste dispersion mit ritonavir, fenofibrat oder griseofulvin
AR003908A1 (es) Tableta de liberacion controlada
AR036972A1 (es) Tableta bioadhesiva de hidratacion progresiva y liberacion sostenida y su uso en la fabricacion de un agente farmaceutico
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
DE60319355D1 (de) Kaubare weichkapsel
MX9203477A (es) Composicion bioactiva.
MX2008000099A (es) Composiciones farmaceuticas de liberacion modificada novedosas, y procedimiento de preparacion de dichas composiciones.
DE60210828D1 (de) Pharmazeutische pellets enthaltend tamsulosin sowie deren herstellungsverfahren
UY27352A1 (es) Formulacion de iniciacion rápida
ATE232100T1 (de) Gegen magensaft geschützte omeprazol- mikrogranülen, herstellungsverfahren und pharmazeutische zubereitungen
ATE326264T1 (de) Pharmazeutische formulierungen mit kontrollierter wirkstoff-freigabe enthaltend milchsäure-polymer, sowie deren herstellung
DE60019334D1 (de) Antivirale arznei
AR021578A1 (es) Formulacion en perlas de pravastatina con revestimiento enterico
DE60017444D1 (de) Pharmazeutische formulierungen auf basis fester dispersionen
DK1194109T3 (da) Topiske formuleringer omfattende hud-gennemtrængningsmidler samt anvendelse deraf
ATE254851T1 (de) Iod-herstellungszusammensetzung
BR9806303A (pt) Sistema de distrituição de droga termoformado, e, unidade de dosagem
SV2006002224A (es) Composicion farmaceutica ref. bhco41368-sv
RS50074B (sr) Farmaceutski preparat koji sadrži paracetamol i drotaverin
BR0202759A (pt) Composição farmacêutica de liberação modificada contendo bupropiona como substância ativa
AR042822A1 (es) Sistema de administracion controlada de farmacos de retencion gastrica con cobertura enterica
ES2130069B1 (es) Preparacion farmaceutica con liberacion retardada del producto activo.

Legal Events

Date Code Title Description
FB Suspension of granting procedure